COVID super-immunity: one of the pandemic's great puzzles.

  title={COVID super-immunity: one of the pandemic's great puzzles.},
  author={Ewen Callaway},

Healthy Nutrition and Immunity: The Correlation Between them for Covid-19 Patients

This paper explores the association between healthy nutrition and Covid -19 to explain the emphasis on healthy nutrition in the pandemic era and clarify any misconception of supplements while promoting effective nutrition to help fight the virus.

Superimmunity by pan-sarbecovirus nanobodies

COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis

Significant clinical effectiveness of COVID-19 vaccination was demonstrated in a multicenter study in HD patients, and the fatality rate within unvaccinated patients within the 4th wave accounted for 11.1%.

Changes Over Time in COVID-19 Incidence, Vaccinations, Serum Spike IgG, and Viral Neutralizing Potential Among Individuals From a North American Gaming Venue

COVID-19 vaccination was associated with a marked decrease in infections; however, individual humoral responses varied and declined significantly over time, as well as potentially important differences in response depending upon vaccine type, prior CO VID-19, autoimmunity, and age.

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

Protection against reinfection decreased as the time increased since the last immunity-conferring event; however, this protection was higher than that conferred after the same time had elapsed since receipt of a second dose of vaccine among previously uninfected persons.

Omicron surge and the future of COVID-19 vaccinations

This literature review aimed to explore the possible steps forward using the most updated knowledge on COVID-19 vaccines and Omicron to alter the future of CO VID-19 vaccinations.

Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims

It is suggested that, while anti-coronavirus vaccines will not magically transport humanity to a non-pandemic world, they may greatly reduce the number of victims of the pandemic and help us learn how to live with COVID-19.

Caregivers' Attitudes Toward COVID-19 Vaccination in Children and Adolescents With a History of SARS-CoV-2 Infection

This preliminary study shows that only about half of the interviewed parents of children and adolescents with a previous SARS-CoV-2 infection are willing to vaccinate them to prevent a repeated COVID-19 infection.



Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

It is suggested that boosting vaccinated individuals with currently available mRNA vaccines will increase plasma neutralizing activity but may not produce antibodies with equivalent breadth to those obtained by vaccinating convalescent individuals.

High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.

Using HIV-1 pseudotypes and plasma-selection experiments with vesicular stomatitis virus/SARS-CoV-2 chimeras5, it is shown that multiple neutralizing epitopes, within and outside the receptor binding domain (RBD), are variably targeted by human polyclonal antibodies.

Differential antibody dynamics to SARS-CoV-2 infection and vaccination

By illuminating an infection-mediated antibody breadth advantage and an anti-SARS-CoV-2 antibody durability-enhancing function conferred by recalled immunity, these findings may serve as guides for ongoing vaccine strategy improvement.

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern

It is observed that boosting of pre-existing immunity with mRNA vaccination in SARS-CoV-2 recovered individuals primarily increased antibody responses in the short-term without significantly altering antibody decay rates or long-term B and T cell memory.

Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection

Whether persons vaccinated after a prior infection have better protection against future infection than those vaccinated without prior infection is investigated and may have implications for dosing, interval between doses, and potential need for booster vaccination.

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.

These studies demonstrate that SARS-CoV-2 mRNA-based vaccination of humans induces a persistent GC B cell response, enabling the generation of robust humoral immunity.

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

The data suggest that immunity in convalescence individuals will be very long lasting and that convalescent individuals who receive available mRNA vaccines will produce antibodies and memory B cells that should be protective against circulating SARS-CoV-2 variants.

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

This study examined whether sera from recovered and naïve donors, collected before and after immunizations with existing messenger RNA (mRNA) vaccines, could neutralize the Wuhan-Hu-1 and B.1.